Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,732,967
-$386,392 QoQ
Shares Held
29,547
-0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#653
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Family Manage LLC holds $23,478,755 across 9 Drug Manufacturers - General names. GILD ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,515 | $11,051,504 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,626 | $4,449,441 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
29,547 | $3,732,967 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
20,516 | $1,182,131 | |
| 5 | LLY |
ELI LILLY & Co
|
890 | $1,067,492 | |
| 6 | ABBV |
AbbVie Inc.
|
4,143 | $1,042,544 | |
| 7 | AMGN |
Amgen Inc
|
1,027 | $371,897 | |
| 8 | PFE |
Pfizer Inc
|
15,274 | $367,797 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,732,967 | 29,547 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,119,359 | 29,557 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,933,459 | 56,489 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,989,227 | 53,957 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,673,883 | 51,176 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,815,816 | 25,130 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||